In Vitro Studies of Persister Cells
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Many bacterial pathogens can permanently colonize their host and establish either chronic or recurrent infections that the immune system and antimicrobial therapies fail to eradicate. Antibiotic persisters (persister cells) are believed to be among the factors that make these infections challenging. Persisters are subpopulations of bacteria which survive treatment with bactericidal antibiotics in otherwise antibiotic-sensitive cultures and were extensively studied in a hope to discover the mechanisms that cause treatment failures in chronically infected patients; however, most of these studies were conducted in the test tube.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 4×
“Nathalie Balaban and her colleagues from the Stanislas Leibler lab made persisters visible and established that they are truly nonproliferating (19).”
BackgroundInfluentialA Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
D’Hulst, G., Soro-Arnaiz, I., Masschelein, E., Veys, K., Fitzgerald, G., Smeuninx, B., Kim, S., Deldicque, L., Blaauw, B., Carmeliet, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13889-6 · Cited by 2,310
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1×
“Bedaquiline is a diarylquinoline compound with a novel mechanism of action that targets the ATP synthase (206).”
BackgroundLewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313 · cited 5×
“seem to be less common than triggered persisters (1).”
BackgroundInfluentialSelf-citationPersistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243 · cited 3×
“Persistent forms of bacterial pathogens are believed to be important contributors toward the failure of antimicrobial therapy of prolonged and recurrent infections (3), such as biofilm formation in vivo (29, 30), tuberculosis (31), urinary tract infections (32), and lung infections in cystic fibrosis patients (33).”
BackgroundMetabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025 · cited 2×
“, arabinose, persisters survive AG treatment, demonstrating that these carbon sources are either not metabolized or do not permeate persister cells (89).”
BackgroundMechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513
ATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508 · cited 1×
“Some studies report an effect of the pH (21, 83, 84) and osmotic shock (85, 86) on bacterial survival after antibiotic exposure, but these effects may vary among the bacterial species and conditions tested (43, 47).”
BackgroundAntimicrobial heteroresistance: An emerging field in need of clarity
El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489 · cited 1×
“A common form of phenotypic resistance is heteroresistance, in which a subpopulation of a clonal population shows reduced antibiotic sensitivity, frequently due to unstable genetic changes (8, 228, 229).”
BackgroundIntracellular Staphylococcus aureus persisters upon antibiotic exposure
Peyrusson, F., Varet, H., Nguyen, T. K., Legendre, R., Sismeiro, O., Coppée, J.-Y., Wolz, C., Tenson, T., & Van Bambeke, F. (2020) · Nature Communications · doi:10.1038/s41467-020-15966-7 · Cited by 392
Self-citationBactericidal effects of antibiotics on slowly growing and nongrowing bacteria
Eng, R. H., Padberg, F. T., Smith, S. M., Tan, E. N., & Cherubin, C. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1824 · Cited by 350
ppGpp is the major source of growth rate control in E. coli
Potrykus, K., Murphy, H., Philippe, N., & Cashel, M. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02357.x · Cited by 251 · cited 2×
“Increased (p)ppGpp levels promote catabolic reactions (148) and repress growth (149, 150) by inhibiting protein synthesis and ribosome assembly (151), as well as transcription of rRNA and ribosomal proteins (152).”
BackgroundAntibiotic resistance: turning evolutionary principles into clinical reality
Andersson, D. I., Balaban, N. Q., Baquero, F., Courvalin, P., Glaser, P., Gophna, U., Kishony, R., Molin, S., & Tønjum, T. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa001 · Cited by 238
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222 · cited 2×
“Despite that, several of them are enrolled in clinical trials (180).”
BackgroundControl of rRNA Expression by Small Molecules Is Dynamic and Nonredundant
Murray, H. D., Schneider, D. A., & Gourse, R. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00266-1 · Cited by 191 · cited 1×
“Transcriptional inhibition occurs directly, by binding of (p)ppGpp to RNA polymerase (153, 154), and indirectly, by depleting the GTP pool (144).”
BackgroundThe impact of the stringent response on TRAFAC GTPases and prokaryotic ribosome assembly.
Bennison, D. J., Irving, S. E., & Corrigan, R. M. (2019) · Cells · doi:10.3390/cells8111313 · Cited by 37 · cited 1×
“Increased (p)ppGpp levels promote catabolic reactions (148) and repress growth (149, 150) by inhibiting protein synthesis and ribosome assembly (151), as well as transcription of rRNA and ribosomal proteins (152).”
BackgroundQuantitative Measurements of Type I and Type II Persisters Using ScanLag
Levin-Reisman, I., & Balaban, N. Q. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2854-5_7 · Cited by 25
Cited by
Inhibitors of bacterial H 2 S biogenesis targeting antibiotic resistance and tolerance
Shatalin, K., Nuthanakanti, A., Kaushik, A., Shishov, D., Peselis, A., Shamovsky, I., Pani, B., Lechpammer, M., Vasilyev, N., Shatalina, E., et al. (2021) · Science · doi:10.1126/science.abd8377 · Cited by 259
Antibiotic failure: Beyond antimicrobial resistance
de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 254
Zeineldin, M., Esmael, A., Al-Hindi, R. R., Alharbi, M. G., Ashenafi Bekele, D., & Teklemariam, A. D. (2023) · Life · doi:10.3390/life13020503 · Cited by 27
Dasilva, M. A., Andrada, K. F. C., Torales, M. M., Hughes, I. M., Pez, P., García-Martínez, J. C., & Paraje, M. G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02415-6 · Cited by 16
“These are associated with recurrent or chronic infections [8, 9].”
Background
Metadata
- Authors
- Kaldalu, N., Hauryliuk, V., Turnbull, K. J., La Mensa, A., Putrinš, M., & Tenson, T.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-11-18
- Volume
- 84
- Issue
- 4
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W3098882283
- Cited by
- 87
- References
- 19
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.